1. Volume 87, Issue 1, Pages 162-168 (January 2015)
Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality 
George R. Bailie, Maria Larkina, David A. Goodkin, Yun Li, Ronald L. Pisoni, Brian Bieber, Nancy Mason, Lin Tong, Francesco Locatelli, Mark R. Marshall, Masaaki Inaba, Bruce M. Robinson 
Kidney International 
Volume 87, Issue 1, Pages (January 2015)
DOI: /ki
Copyright © 2015 International Society of Nephrology Terms and Conditions

2. Figure 1
Associations of intravenous (IV) iron dose categories with (a) all-cause mortality and (b) cause-specific mortality. IV iron dose is the total 4-month dose, expressed as average mg/month. Model details are provided in text. Adjustments and effect estimates (95% confidence interval (CI)) are as per Model 6 in Table 2. CV, cardiovascular.
Kidney International  , DOI: ( /ki )
Copyright © 2015 International Society of Nephrology Terms and Conditions